ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
Europe - BIT:1LLY - US5324571083 - Common Stock
615.8 EUR
-28.4 (-4.41%)
We assign a fundamental rating of 6 out of 10 to 1LLY. 1LLY was compared to 50 industry peers in the Pharmaceuticals industry. While 1LLY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1LLY is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year 1LLY was profitable.
In the past year 1LLY had a positive cash flow from operations.
In the past 5 years 1LLY has always been profitable.
In the past 5 years 1LLY always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 13.67%, 1LLY belongs to the best of the industry, outperforming 86.00% of the companies in the same industry.
The Return On Equity of 1LLY (75.52%) is better than 98.00% of its industry peers.
With an excellent Return On Invested Capital value of 29.63%, 1LLY belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1LLY is significantly above the industry average of 15.33%.
The 3 year average ROIC (21.71%) for 1LLY is below the current ROIC(29.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROIC | 29.63% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
The Profit Margin of 1LLY (25.91%) is better than 90.00% of its industry peers.
In the last couple of years the Profit Margin of 1LLY has declined.
The Operating Margin of 1LLY (42.13%) is better than 96.00% of its industry peers.
1LLY's Operating Margin has improved in the last couple of years.
1LLY's Gross Margin of 82.64% is amongst the best of the industry. 1LLY outperforms 86.00% of its industry peers.
1LLY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1LLY is creating value.
The number of shares outstanding for 1LLY remains at a similar level compared to 1 year ago.
1LLY has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1LLY is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.60 indicates that 1LLY is not in any danger for bankruptcy at the moment.
1LLY's Altman-Z score of 6.60 is amongst the best of the industry. 1LLY outperforms 86.00% of its industry peers.
A Debt/Equity ratio of 1.87 is on the high side and indicates that 1LLY has dependencies on debt financing.
With a Debt to Equity ratio value of 1.87, 1LLY is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.6 |
ROIC/WACC3.06
WACC9.68%
2.3 Liquidity
A Current Ratio of 1.28 indicates that 1LLY should not have too much problems paying its short term obligations.
1LLY's Current ratio of 1.28 is in line compared to the rest of the industry. 1LLY outperforms 48.00% of its industry peers.
1LLY has a Quick Ratio of 1.28. This is a bad value and indicates that 1LLY is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 1.00, 1LLY perfoms like the industry average, outperforming 54.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
1LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.67%, which is quite impressive.
Measured over the past years, 1LLY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.57% on average per year.
Looking at the last year, 1LLY shows a very strong growth in Revenue. The Revenue has grown by 36.83%.
The Revenue has been growing by 15.08% on average over the past years. This is quite good.
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
3.2 Future
Based on estimates for the next years, 1LLY will show a very strong growth in Earnings Per Share. The EPS will grow by 30.30% on average per year.
The Revenue is expected to grow by 17.76% on average over the next years. This is quite good.
EPS Next Y76.85%
EPS Next 2Y53.25%
EPS Next 3Y42.28%
EPS Next 5Y30.3%
Revenue Next Year36.76%
Revenue Next 2Y27.21%
Revenue Next 3Y23.13%
Revenue Next 5Y17.76%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1LLY is valuated quite expensively with a Price/Earnings ratio of 44.75.
Based on the Price/Earnings ratio, 1LLY is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.32, 1LLY is valued quite expensively.
A Price/Forward Earnings ratio of 23.68 indicates a rather expensive valuation of 1LLY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 60.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.89. 1LLY is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.75 | ||
| Fwd PE | 23.68 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 66.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 29.61 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1LLY has an outstanding profitability rating, which may justify a higher PE ratio.
1LLY's earnings are expected to grow with 42.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)2.7
EPS Next 2Y53.25%
EPS Next 3Y42.28%
5. Dividend
5.1 Amount
With a yearly dividend of 0.79%, 1LLY is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.07, 1LLY has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, 1LLY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.79% |
5.2 History
On average, the dividend of 1LLY grows each year by 15.60%, which is quite nice.
Dividend Growth(5Y)15.6%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
36.46% of the earnings are spent on dividend by 1LLY. This is a low number and sustainable payout ratio.
The dividend of 1LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP36.46%
EPS Next 2Y53.25%
EPS Next 3Y42.28%
BIT:1LLY (9/25/2025, 7:00:00 PM)
615.8
-28.4 (-4.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners84.01%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap582.83B
Analysts80
Price Target771.26 (25.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.79% |
Yearly Dividend4.2
Dividend Growth(5Y)15.6%
DP36.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.94%
Min EPS beat(2)9.38%
Max EPS beat(2)14.51%
EPS beat(4)3
Avg EPS beat(4)2.5%
Min EPS beat(4)-20.34%
Max EPS beat(4)14.51%
EPS beat(8)7
Avg EPS beat(8)31.01%
EPS beat(12)10
Avg EPS beat(12)22.08%
EPS beat(16)12
Avg EPS beat(16)15.86%
Revenue beat(2)1
Avg Revenue beat(2)2.11%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)4.72%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-6.46%
Max Revenue beat(4)4.72%
Revenue beat(8)4
Avg Revenue beat(8)1.92%
Revenue beat(12)6
Avg Revenue beat(12)1.89%
Revenue beat(16)9
Avg Revenue beat(16)1.54%
PT rev (1m)-8.67%
PT rev (3m)-11.45%
EPS NQ rev (1m)0.33%
EPS NQ rev (3m)3.8%
EPS NY rev (1m)0%
EPS NY rev (3m)5.27%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)4.43%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)3.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.75 | ||
| Fwd PE | 23.68 | ||
| P/S | 12.85 | ||
| P/FCF | N/A | ||
| P/OCF | 62.55 | ||
| P/B | 37.44 | ||
| P/tB | 103.76 | ||
| EV/EBITDA | 29.61 |
EPS(TTM)13.76
EY2.23%
EPS(NY)26.01
Fwd EY4.22%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)9.84
OCFY1.6%
SpS47.93
BVpS16.45
TBVpS5.94
PEG (NY)0.58
PEG (5Y)2.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROCE | 36.25% | ||
| ROIC | 29.63% | ||
| ROICexc | 31.43% | ||
| ROICexgc | 39.29% | ||
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% | ||
| FCFM | N/A |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexcg growth 3Y1.59%
ROICexcg growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.81%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.4 | ||
| Cap/Depr | 580.51% | ||
| Cap/Sales | 20.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 44.95% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 6.6 |
F-Score6
WACC9.68%
ROIC/WACC3.06
Cap/Depr(3y)374.28%
Cap/Depr(5y)279.43%
Cap/Sales(3y)16.34%
Cap/Sales(5y)12.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
EPS Next Y76.85%
EPS Next 2Y53.25%
EPS Next 3Y42.28%
EPS Next 5Y30.3%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
Revenue Next Year36.76%
Revenue Next 2Y27.21%
Revenue Next 3Y23.13%
Revenue Next 5Y17.76%
EBIT growth 1Y67.12%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year84.34%
EBIT Next 3Y42.93%
EBIT Next 5Y29.73%
FCF growth 1Y-101.56%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y75.24%
OCF growth 3Y6.69%
OCF growth 5Y12.76%